Media coverage
10Media coverage
Title Positive Interim Data from ReSPECT(TM) Phase 1 Clinical Trial in Recurrent Glioblastoma Media name/outlet Market News Publishing Country United States Date 11/19/20 Persons Andrew Brenner Title Plus Therapeutics Announces Positive Interim Data from ReSPECT Phase 1 Clinical Trial in Recurrent Glioblastoma Media name/outlet India Pharma News Country India Date 11/19/20 Persons Andrew Brenner Title Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma Media name/outlet Yahoo! Finance Country United States Date 11/19/20 Persons Andrew Brenner Title Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma Media name/outlet MarketScreener.com Country United States Date 11/19/20 Persons Andrew Brenner Title Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma Media name/outlet Jotup Country United States Date 11/19/20 Persons Andrew Brenner Title Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma Media name/outlet BioSpace Country United States Date 11/19/20 Persons Andrew Brenner Title Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma Media name/outlet Biotechgate Country Switzerland Date 11/19/20 Persons Andrew Brenner Title Plus Therapeutics Announces Positive Interim Data from ReSPECT„¢ Phase 1 Clinical Trial in Recurrent Glioblastoma Media name/outlet PrimeNewswire (Top News) Country United States Date 11/19/20 Persons Andrew Brenner Title Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma Media name/outlet GlobeNewswire Country United States Date 11/19/20 Persons Andrew Brenner Title Plus Therapeutics Announces Positive Interim Data from ReSPECT(TM) Phase 1 Clinical Trial in Recurrent Glioblastoma Media name/outlet Newbridge Securities Corporation Country United States Date 11/19/20 Persons Andrew Brenner